Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study.

Macintyre CR, Heywood AE, Kovoor P, Ridda I, Seale H, Tan T, Gao Z, Katelaris AL, Siu HW, Lo V, Lindley R, Dwyer DE.

Heart. 2013 Dec;99(24):1843-8. doi: 10.1136/heartjnl-2013-304320. Epub 2013 Aug 21.

2.

Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial.

Fröbert O, Götberg M, Angerås O, Jonasson L, Erlinge D, Engstrøm T, Persson J, Jensen SE, Omerovic E, James SK, Lagerqvist B, Nilsson J, Kåregren A, Moer R, Yang C, Agus DB, Erglis A, Jensen LO, Jakobsen L, Christiansen EH, Pernow J.

Am Heart J. 2017 Jul;189:94-102. doi: 10.1016/j.ahj.2017.04.003. Epub 2017 Apr 18.

3.

The Bradford-Hill criteria and evidence of association between influenza vaccination and ischaemic heart disease.

Macintyre CR, Heywood AE.

Heart. 2014 Mar;100(6):518-9. doi: 10.1136/heartjnl-2013-305435. Epub 2014 Jan 23. No abstract available.

PMID:
24459292
4.

Acute myocardial infarction and influenza: a meta-analysis of case-control studies.

Barnes M, Heywood AE, Mahimbo A, Rahman B, Newall AT, Macintyre CR.

Heart. 2015 Nov;101(21):1738-47. doi: 10.1136/heartjnl-2015-307691. Epub 2015 Aug 26.

5.

Ischaemic heart disease, influenza and influenza vaccination: a prospective case control study.

Rogawski E, McGrath L, Vielot N, Westreich D.

Heart. 2014 Mar;100(6):517-8. doi: 10.1136/heartjnl-2013-305406. Epub 2014 Jan 16. No abstract available.

6.

The burden of influenza in healthy children in South Australia.

D'Onise K, Raupach JC.

Med J Aust. 2008 May 5;188(9):510-3.

PMID:
18459921
7.

Description of the Western Sydney and Nepean Blue Mountains local health districts' influenza prevention programme.

Brown M, Sheppeard V, Gabriel S, Thomas J.

Intern Med J. 2013 Jul;43(7):760-6. doi: 10.1111/imj.12175.

PMID:
23656638
8.

Prospective hospital-based case-control study to assess the effectiveness of pandemic influenza A(H1N1)pdm09 vaccination and risk factors for hospitalization in 2009-2010 using matched hospital and test-negative controls.

Hellenbrand W, Jorgensen P, Schweiger B, Falkenhorst G, Nachtnebel M, Greutélaers B, Traeder C, Wichmann O.

BMC Infect Dis. 2012 May 31;12:127. doi: 10.1186/1471-2334-12-127.

9.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

PMID:
22277542
10.

Influenza vaccination of healthcare workers in acute-care hospitals: a case-control study of its effect on hospital-acquired influenza among patients.

Bénet T, Régis C, Voirin N, Robert O, Lina B, Cronenberger S, Comte B, Coppéré B, Vanhems P.

BMC Infect Dis. 2012 Feb 1;12:30. doi: 10.1186/1471-2334-12-30.

11.

Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study.

Lau D, Eurich DT, Majumdar SR, Katz A, Johnson JA.

Thorax. 2013 Jul;68(7):658-63. doi: 10.1136/thoraxjnl-2012-203109. Epub 2013 Mar 27.

12.

Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study.

Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B.

Eur Heart J. 2004 Jan;25(1):25-31.

PMID:
14683739
13.

Survey of Australian inpatients on vaccination status and perceptions of influenza vaccination.

Loke XY, Tran W, Alderman CP.

Consult Pharm. 2012 Aug;27(8):553-63. doi: 10.4140/TCP.n.2012.553.

PMID:
22910176
14.

Using surveillance data to estimate pandemic vaccine effectiveness against laboratory confirmed influenza A(H1N1)2009 infection: two case-control studies, Spain, season 2009-2010.

Savulescu C, Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, Breña PP, Galmés A, Vanrell JM, Rodriguez C, Vega T, Martinez A, Torner N, Ramos JM, Serrano MC, Castilla J, Cenoz MG, Altzibar JM, Arteagoitia JM, Quiñones C, Perucha M, Larrauri A.

BMC Public Health. 2011 Nov 30;11:899. doi: 10.1186/1471-2458-11-899.

15.

Effectiveness of the influenza vaccine at preventing hospitalization due to acute lower respiratory infection and exacerbation of chronic cardiopulmonary disease in Korea during 2010-2011.

Seo YB, Hong KW, Kim IS, Choi WS, Baek JH, Lee J, Song JY, Lee JS, Cheong HJ, Kim WJ.

Vaccine. 2013 Feb 27;31(10):1426-30. doi: 10.1016/j.vaccine.2012.10.024. Epub 2012 Oct 19.

PMID:
23084847
16.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
17.

Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study.

Ciszewski A, Bilinska ZT, Brydak LB, Kepka C, Kruk M, Romanowska M, Ksiezycka E, Przyluski J, Piotrowski W, Maczynska R, Ruzyllo W.

Eur Heart J. 2008 Jun;29(11):1350-8. doi: 10.1093/eurheartj/ehm581. Epub 2008 Jan 10.

PMID:
18187561
18.

Antiviral drugs in influenza: an adjunct to vaccination in some situations.

[No authors listed]

Prescrire Int. 2006 Feb;15(81):21-30.

PMID:
16548114
19.

Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations.

Louie JK, Schechter R, Honarmand S, Guevara HF, Shoemaker TR, Madrigal NY, Woodfill CJ, Backer HD, Glaser CA.

Pediatrics. 2006 Apr;117(4):e610-8.

PMID:
16585278
20.

Influenza vaccination in secondary prevention: an opportunity missed.

Bittner V, Sanderson BK.

J Cardiopulm Rehabil Prev. 2007 Jul-Aug;27(4):202-7.

PMID:
17667013

Supplemental Content

Support Center